Thesis (Ph. D.)--University of Missouri-Columbia, 1996. / Typescript. Vita. Includes bibliographical references (leaves 129-157). Also available on the Internet.

Thesis (Ph. D.)--University of Missouri-Columbia, 1996. / Typescript. Vita. Includes bibliographical references (leaves 129-157). Also available on the Internet.

Thesis (doctoral)--University of Lund, 1981. / "From the Departments of Infectious Diseases and Clinical Bacteriology, University of Lund, General Hospital, Malmö, Sweden." "The English text revised by L. James Brown." Bibliography: p. 29-33.

Cancer cells require survival strategies to respond to microenviromental changes and out-compete their neighbours. They activate stress response mechanisms under extreme microenvironmental conditions, some of which are controlled by the amino acid-sensitive kinase complex, mechanistic Target of Rapamycin Complex 1 (mTORC1). Exosomes are secreted nanovesicles made inside intracellular endosomal compartments that mediate a specialised and complex form of intercellular signalling that can reprogramme target cells via the action of multiple active cargos. I investigated whether mTORC1 activity might modulate the type of exosome secreted in response to microenvironmental changes. Here I identify a new form of mTORC1-regulated exosome biogenesis and signalling involving recycling multivesicular endosomes (rMVEs), a previously unrecognised site for exosome biogenesis. Reduced activity of a specific form of glutamine-sensitive mTORC1 in HCT116 colorectal cancer cells results in an ‘exosome switch’ in which exosomes are preferentially released from these compartments instead of late endosomes. Importantly, RAB11a is found in association with at least a proportion of rMVEs that generate these alternative exosomes and is loaded on to some of their ILVs, providing a RAB signature of compartmental origin. I provide evidence that this exosome switch is conserved in other cancer cell types. My study also presents a proteomics analysis of extracellular vesicle (EV) preparations from normal and mTORC1-inhibited cells. I demonstrate that EV preparations isolated following exosome switching have enhanced pro-angiogenic properties and novel tumour growth-promoting activities. Activation of the receptor tyrosine kinase c-MET and its downstream mitogen-activated protein kinase (MAPK) ERK via phosphorylation is stimulated by these EVs, providing a potential explanation for their growth-promoting effects. Subsequent studies in the lab have demonstrated that several of these pro-tumorigenic activities are mediated by exosomes. I conclude that stress-induced mTORC1 inhibition allows tumour cells to initiate a novel exosome secretion pathway that potentially mediates a cancer cell survival plan that reverses microenvironmental change and supports tumour adaptation. In the future, blocking this response could improve patient outcome following treatment with mTORC1-inhibitory or anti-angiogenic drugs that have currently met with limited success in the clinic.

Orientadores: Paulo Pinto Joazeiro, Cláudio Chrysostomo Werneck / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-18T04:27:14Z (GMT). No. of bitstreams: 1 Consonni_SilvioRoberto_M.pdf: 3398352 bytes, checksum: 7a1238aba907982b903dec23fbc0470d (MD5) Previous issue date: 2011 / Resumo: A organização das fibras elásticas envolve a síntese e a deposição de moléculas em uma sequência altamente regulada para assegurar as características elásticas nos estágios iniciais do desenvolvimento. Durante e prenhez, os tecidos pélvicos ricos em fibras elásticas se alteram para permitir um parto seguro e essa remodelação é essencial para o parto normal. A sínfise púbica de camundongos também remodela em um processo controlado por hormônios. Este fenômeno compreende a "transformação" da fibrocartilagem em um ligamento interpúbico (LIp) seguido por seu relaxamento antes do parto. Após o primeiro parto, o processo de retorno ocorre e assegura a homeostase dos tecidos pélvicos. Ainda, alterações no suporte dos órgãos pélvicos foram descritas em animais geneticamente modificados para proteínas envolvidas na elastogênese como a lysyl oxidase-like 1 (LOXL1), fibulina-3 e 5. Como ligamentos são as principais estruturas de suporte dos órgãos pélvicos, o objetivo deste estudo foi avaliar a elastogênse no desenvolvimento do LIp durante a prenhez de camundongos. Assim, camundongos selvagens C57Bl/06 e deficientes em fibrilina-1 virgens, prênhes e no pós-parto foram estudados usando microscopia de luz convencional, microscopia confocal a laser, microscopia eletrônica de transmissão, western blotting e real-time PCR. Ambos os animais selvagens e deficientes em fibrilina-1 apresentaram classicamente a separação dos ossos púbicos, a formação e relaxamento do LIp e a involução deste no pós-parto. Esses processos sugeriram um padrão no qual as células controlam a remodelação da matriz extracelular sob sinalização hormonal e molecular. A ultra-estrutura dos tecidos fibrocartilaginosos apresentou delgadas microfibrilas aleatoriamente distribuídas entre os fibrocondrócitos. Na formação do LIp, foram observadas fibras elásticas com conglomerados de material amorfo distribuídos entre as microfibrilas. O LIp mostrou fibras elásticas e todos os componentes teciduais alinhados na direção da abertura da articulação interpúbica antes do parto. O estudo imuno-histoquímico e de expressão gênica relativa quantitativa indicou que durante o desenvolvimento do LIp em camundongos selvagens, elastina/tropoelastina, fibrilina-1 e 2, LOXL1, fibulina-5 e TGF-? foram regulados espacial e temporalmente, e estas moléculas poderiam contribuir para a síntese de novas fibras elásticas que asseguram a elasticidade necessária para a cintura pélvica durante o preparo para o parto e também no fechamento da articulação no pós-parto. Entretanto, se comparados com o animal selvagem, a análise indicou alteração na expressão gênica relativa da tropoelastina, fibrilina-1, LOXL1, fibulina-5 e TGF-?, diferentemente da morfologia muito similar observada em camundongos selvagens. Neste estudo, o camundongo deficiente em fibrilina-1 não apresentou prolapso de órgãos pélvicos após o primeiro parto como o deficiente em LOXL1 (Liu et al., 2004), nem modificações morfológicas que poderiam ser relacionadas ao enfraquecimento dos tecidos pélvicos. No entanto, este é o primeiro estudo que relata disfunções pélvicas nos camundongos deficientes em fibrilina-1 multíparos, usados como matrizes reprodutivas. Em conclusão, a formação das fibras elásticas que ocorreu na sínfise púbica de camundongos durante a vida adulta possui características únicas de um modelo que pode ser usado para compreensão dos processos normais e patológicos, principalmente aqueles relacionados aos animais geneticamente modificados para proteínas envolvidas na elastogênese. Assim, este trabalho traz à luz as evidências das profundas modificações que a sínfise púbica de camundongos passa durante a prenhez com a síntese de novas fibras elásticas, o que pode contribuir na compreensão dos mecanismos biológicos para formação das fibras elásticas / Abstract: The organization of elastic fibers involves the synthesis and the deposition of molecules in a high regulated sequence to ensure the elastic characteristics in the early stages of development. During pregnancy, elastic fibers-enriched pelvic tissues change to allow safe delivery and this remodeling is essential to the vaginal delivery. The mouse pubic symphysis articulation also remodels in a controlled hormonal process. This phenomenon comprises the "transformation" of the fibrocartilage into an interpubic ligament (IpL) followed by its relaxation before parturition. After the first parturition, recovery process occurs to ensure the pelvic tissue homeostasis. Adding to that, pelvic organ support impairment had been described in genetically modified mouse for the proteins involved in the elastogenesis such as lysyl oxidase-like 1 (LOXL-1), fibulin-3 and -5. Since, ligaments are the main supportive structures of pelvic organs, the aim of this study was to evaluate the elastogenesis in the IpL development during mouse pregnancy. Thus virgin, pregnant and postpartum C57Bl/06 wild-type and fibrillin-1mg?/+ female mice were studied using light, confocal, transmission electron microscopy, western blotting and real-time PCR. Both, wild-type and fibrillin-1mg?/+ female mice showed classically the separation of the pubic bones, the formation and relaxation of the IpL and the recovery at postpartum. These processes suggested a pattern which cells control the extracellular matrix remodeling under hormonal and molecular signaling. The ultra-structure of the fibrocartilaginous tissue had slender bundles of microfibrils randomly distributed among the fibrochondrocytes. By the time IpL is formed, there were seen elastic fibers, which consist of small conglomerates of amorphous material, distributed among the bundles of microfibrils. The IpL showed elastic fibers and all tissue compounds aligned to the opening axis of the articulation before parturition. The immunohistochemical study and quantitative gene expression indicated that during IpL development in wild-type mice, tropoelastin/elastin, fibrillin-1, fibrillin-2, LOXL-1, fibulin-5 and TGF-? were spatial and temporal regulated, and these molecules might contribute to the synthesis of new elastic fibers that assure the elasticity that is needed to the pelvic girdle during preparation for parturition and also the recovery at postpartum. However, compared to wild-type mice, alterations were found in the quantitative gene expression of elastin, fibrillin-1, LOXL-1, fibulin-5 and TGF- ?, different from the morphology that was very similar to the one that was observed in wild-type mice. In this study, the fibrillinmg?/+ mice did not show pelvic organ prolapse after the first parturition as LOXL1-/- did (Liu et al., 2004), neither morphological modifications that could be related to the weakness of pelvic tissue. However, this is the first work about pelvic dysfunctions in multiparous fibrillin-1mg?/+ mice used as reproductive matrices. In conclusion, the elastic fiber assembly that occurred in the mouse pubic symphysis during the adult life has characteristics of a model that could be used to understand normal and pathological processes, mainly those related to genetically modified mice for the proteins involved in the elastogenesis. Then, this work may bring readers up-to-date with accumulating evidence that the mouse pubic symphysis undergoes remarkable modifications during pregnancy with new synthesized elastic fibers and may contribute to our understanding of the biological mechanisms about elastic fiber assembly / Mestrado / Histologia / Mestre em Biologia Celular e Estrutural

Cell-derived (CDM) matrix scaffolds provide a 3-dimensional (3D) matrix material that recapitulates a native, human extracellular matrix (ECM) microenvironment. CDMs are a heterogeneous source of ECM proteins with a composition dependent on the cell source and its phenotype. CDMs have several applications, such as for development of cell culture substrates to study stromal cell propagation and differentiation, as well as cell or drug delivery vehicles, or for regenerative biomaterial applications. Although CDMs are versatile and exhibit advantageous structure and activity, their use has been hindered due to the prolonged culture time required for ECM deposition and maturation in vitro. Macromolecular crowding (MMC) has been shown to increase ECM deposition and organization by limiting the diffusion of ECM precursor proteins and allowing the accumulation of matrix at the cell layer. A commonly used crowder that has been shown to increase ECM deposition in vitro is Ficoll, and was used in this study as a positive control to assess matrix deposition. Hyaluronic acid (HA), a natural crowding macromolecule expressed at high levels during fetal development, has been shown to play a role in ECM production, organization, and assembly in vivo. HA has not been investigated as a crowding molecule for matrix deposition or development of CDMs in vitro. This dissertation focused on 2 aims supporting the development of a functional, human dermal fibroblast-derived ECM material for the delivery deliver an antimicrobial peptide, cCBD-LL37, and for potentially promoting a pro-angiogenic environment. The goal of this thesis was to evaluate the effects of high molecular weight (HMW) HA as a macromolecular crowding agent on in vitro deposition of ECM proteins important for tissue regeneration and angiogenesis. A pilot proteomics study supported the use of HA as a crowder, as it preliminarily showed increases in ECM proteins and increased retention of ECM precursor proteins at the cell layer; thus supporting the use of HA as a crowder molecule. In the presence of HA, human dermal fibroblasts demonstrated an increase in ECM deposition comparable to the effects of Ficoll 70/400 at day 3 using Raman microspectroscopy. It was hypothesized that HA promotes matrix deposition through changes on ECM gene expression. However, qRT-PCR results indicate that HA and Ficoll 70/400 did not have a direct effect on collagen gene expression, but differences in matrix crosslinking and proteinase genes were observed. Decellularized CDMs were then used to assess CDM stiffness and endothelial sprouting, which indicated differences in structural organization of collagen, and preliminarily suggests that there are differences in endothelial cell migration depending on the crowder agent used in culture. Finally, the collagen retained in the decellularized CDM matrix prepared under MMC supported the binding of cCBD-LL37 with retention of antimicrobial activity when tested against E.coli. Overall, the differences in matrix deposition profiles in HA versus Ficoll crowded cultures may be attributed to crowder molecule-mediated differences in matrix crosslinking, turnover, and organization as indicated by differences in collagen deposition, matrix metalloproteinase expression, and matrix stiffness. MMC is a valuable tool for increasing matrix deposition, and can be combined with other techniques, such as low oxygen and bioreactor cultures, to promote development of a biomanufactured CDM-ECM biomaterial. Successful development of scalable CDM materials that stimulate angiogenesis and support antimicrobial peptide delivery would fill an important unmet need in the treatment of non-healing, chronic, infected wounds.

The process of aging causes the major changes in nervous tissue such as changes in the size of brain, architecture of glial cells and extracellular matrix. The size of brain is on the decrease as consequence of aging and there is a change of molecules as well as morphology at all levels. Extracellular space (ECS) is interstitium important especially in communication between cells mediated by diffusion. The limit of diffusion in extracellular space is given by size of ECS, which is discribed by volume fraction and tortuosity, that reflect amount of diffusion barriers. The changes of ECS diffusion parameters during aging were measured by real-time iontophoretic method in four parts of brain (cortex - Cx, hippocampus - Hp, inferior colliculus - IC and corpus trapezoideum - TB). Further, we studied influence of deficiency of Bral2 link protein at differences of ECS diffusion parameters and importance of Bral2 protein at aging and regulation mechanisms of cytotoxic brain edema. Our results show, that aging leads to decreasing of ECS volume v Cx and Hp, but it was not observed in IC and TB, where the intact perineuronal nets act like protecting shield against the degenerative disease induced by aging. However, small differences in composition of perineuronal nets, deficiency of Bral2 link protein, may...

Cell-derived (CDM) matrix scaffolds provide a 3-dimensional (3D) matrix material that recapitulates a native, human extracellular matrix (ECM) microenvironment. CDMs are a heterogeneous source of ECM proteins with a composition dependent on the cell source and its phenotype. CDMs have several applications, such as for development of cell culture substrates to study stromal cell propagation and differentiation, as well as cell or drug delivery vehicles, or for regenerative biomaterial applications. Although CDMs are versatile and exhibit advantageous structure and activity, their use has been hindered due to the prolonged culture time required for ECM deposition and maturation in vitro. Macromolecular crowding (MMC) has been shown to increase ECM deposition and organization by limiting the diffusion of ECM precursor proteins and allowing the accumulation of matrix at the cell layer. A commonly used crowder that has been shown to increase ECM deposition in vitro is Ficoll, and was used in this study as a positive control to assess matrix deposition. Hyaluronic acid (HA), a natural crowding macromolecule expressed at high levels during fetal development, has been shown to play a role in ECM production, organization, and assembly in vivo. HA has not been investigated as a crowding molecule for matrix deposition or development of CDMs in vitro. This dissertation focused on 2 aims supporting the development of a functional, human dermal fibroblast-derived ECM material for the delivery deliver an antimicrobial peptide, cCBD-LL37, and for potentially promoting a pro-angiogenic environment. The goal of this thesis was to evaluate the effects of high molecular weight (HMW) HA as a macromolecular crowding agent on in vitro deposition of ECM proteins important for tissue regeneration and angiogenesis. A pilot proteomics study supported the use of HA as a crowder, as it preliminarily showed increases in ECM proteins and increased retention of ECM precursor proteins at the cell layer; thus supporting the use of HA as a crowder molecule. In the presence of HA, human dermal fibroblasts demonstrated an increase in ECM deposition comparable to the effects of Ficoll 70/400 at day 3 using Raman microspectroscopy. It was hypothesized that HA promotes matrix deposition through changes on ECM gene expression. However, qRT-PCR results indicate that HA and Ficoll 70/400 did not have a direct effect on collagen gene expression, but differences in matrix crosslinking and proteinase genes were observed. Decellularized CDMs were then used to assess CDM stiffness and endothelial sprouting, which indicated differences in structural organization of collagen, and preliminarily suggests that there are differences in endothelial cell migration depending on the crowder agent used in culture. Finally, the collagen retained in the decellularized CDM matrix prepared under MMC supported the binding of cCBD-LL37 with retention of antimicrobial activity when tested against E.coli. Overall, the differences in matrix deposition profiles in HA versus Ficoll crowded cultures may be attributed to crowder molecule-mediated differences in matrix crosslinking, turnover, and organization as indicated by differences in collagen deposition, matrix metalloproteinase expression, and matrix stiffness. MMC is a valuable tool for increasing matrix deposition, and can be combined with other techniques, such as low oxygen and bioreactor cultures, to promote development of a biomanufactured CDM-ECM biomaterial. Successful development of scalable CDM materials that stimulate angiogenesis and support antimicrobial peptide delivery would fill an important unmet need in the treatment of non-healing, chronic, infected wounds.

Detection of cancer at the early stages greatly increases the chance for successful treatment and favourable prognosis for patients. However, a liquid-based biopsy has yet to be developed for most cancers. Extracellular vesicles (EVs) are an attractive candidate for early cancer detection since their surface proteome mirrors the cell of origin. Thus, there is a need for the development of reliable probes that can detect cancer derived EVs. In this thesis, the VBS-1 aptamer was developed to selectively bind to triple-negative breast cancer cell line derived EVs. Initially, several EV isolation methods were compared and isolated EVs were validated and characterized. Aptamer clones were developed by Systematic Evolution of Ligands by Exponential Enrichment to EVs isolated by differential ultracentrifugation and their binding was validated by flow cytometry. The binding partner of the selected VBS-1 aptamer was identified by LC-MS/MS to be the transmembrane protein ATP1A1. The presence of an ATP1A1-positive EV population was validated by flow cytometry. The selected aptamer may find further application in biosensors for the detection of EVs as cancer biomarkers in biological fluids.

Neutrophil extracellular traps (NETs) are a link between infection and coagulation in sepsis. The major structural component of NETs is nucleosomes, consisting of DNA and histones. NETs not only act as a scaffold to trap platelets, but NET components also promote coagulation and impair fibrinolysis. Thus, removal of extracellular DNA by DNases may be a potential therapeutic strategy for sepsis. Since heparin is used for thromboprophylaxis in sepsis and may also be a potential anti-sepsis therapy, we investigated the mechanisms by which various forms of heparins modulate DNase function. There are two types of DNases in vivo: DNase I (produced by exocrine and endocrine glands) and DNase1L3 (secreted by immune cells). DNase I cleaves free DNA, whereas DNase1L3 preferentially cleaves DNA in complex with proteins such as histones. In this study, we investigated how DNase I and DNase1L3 activities are modulated by the following heparins: unfractionated heparin (UFH), enoxaparin (a low-molecular-weight heparin), Vasoflux (a low-molecular-weight, non-anticoagulant heparin), and fondaparinux (the pentasaccharide unit). Using agarose gel experiments, we showed that UFH, enoxaparin, and Vasoflux enhance the ability of DNase I to digest DNA-histone complexes (presumably by displacing DNA from histones), whereas fondaparinux does not. These findings are consistent with the KD values of the binding of heparin variants to histones, with fondaparinux having >1000-fold lower affinity for histones compared to the other heparins. Taken together, our data suggests that the ability of heparin to enhance DNase I-mediated digestion of DNA-histone complexes is size-dependent and independent of the pentasaccharide region of heparin. With respect to DNase1L3, we observed that it is able to digest histone-bound DNA, and that all heparins, except fondaparinux, inhibited DNase1L3-mediated digestion of histone-bound DNA. Next, we visualized the degradation of NETs by fluorescence microscopy. DNase I (± heparin variants) completely degraded NETs, presumably by digesting extracellular chromatin at histone-free linker regions, thereby releasing nucleosome units. DNase1L3 also degraded NETs, but not as effectively as DNase I, and was inhibited by all heparins except fondaparinux. Finally, we showed that DNase I levels are decreased and DNase1L3 levels are elevated in septic patients. Taken together, our findings demonstrate that heparin modulates the function of DNases, and that endogenous DNase levels are altered in sepsis pathophysiology. / Thesis / Master of Science (MSc) / Sepsis, a life-threatening condition due to hyperactivation of the immune system in response to infection, results in widespread inflammation and blood clotting. During sepsis, immune cells release sticky strands of DNA that block blood vessels and damage organs. Two different enzymes in the blood (DNase I and DNase1L3) can digest these DNA strands, and may represent a new class of anti-sepsis drugs. Our goal was to determine how heparins, commonly used blood thinners, alter the function of these enzymes. We found that (a) larger-sized heparins improved the activity of DNase I towards DNA-histone complexes and do not require any specific portion of heparin, (b) DNase I is more efficient than DNase1L3 in digesting DNA strands released from immune cells, and (c) levels of DNase I and DNase1L3 are altered in septic patients. Taken together, our studies provide new insights into how these enzymes function.